FLC
JNCE

Fifth Lane Capital’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Fifth Lane Capital’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-50,000
Closed -$92.5K – 229
2023
Q1 		$92.5K Buy
+50,000
New +$92.5K 0.05% 42